STOCK TITAN

Vanguard (NASDAQ: GERN) discloses 0 share ownership after realignment

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group filed an Amendment No. 1 to a Schedule 13G/A stating it beneficially owns 0 shares of Geron Corp, representing 0% of the class. The filing explains an internal realignment effective January 12, 2026, under SEC Release No. 34-39538 that caused certain Vanguard subsidiaries/divisions to report separately. The amendment is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.

Positive

  • None.

Negative

  • None.

Insights

Vanguard reports no beneficial ownership in Geron after internal reorganization.

The filing lists 0 shares and 0% ownership; it attributes the change to an internal realignment dated January 12, 2026 under SEC Release No. 34-39538, which causes disaggregated reporting by subsidiaries.

Cash‑flow treatment or trading intent is not stated; subsequent filings by the listed Vanguard entities may show holdings if they retain positions. The practical effect is administrative reclassification of reporting responsibility rather than an explicit market transaction.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026

FAQ

Does The Vanguard Group own any Geron (GERN) shares?

No, the filing states 0 shares and 0% ownership. The Amendment No. 1 explains an internal realignment effective January 12, 2026 that caused certain Vanguard subsidiaries or divisions to report beneficial ownership separately under SEC guidance.

Why does Vanguard say it owns 0 shares of Geron (GERN)?

Because Vanguard reorganized internally and disaggregated reporting for subsidiaries. The filing cites SEC Release No. 34-39538, noting formerly aggregated holdings are now reported separately by subsidiaries or business divisions after the realignment.

Who signed the Schedule 13G/A amendment for Vanguard?

The amendment is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026. The signature attests to the filing details about beneficial ownership and the internal realignment described in the filing.

Does this filing indicate Vanguard sold Geron (GERN) shares?

No, the filing does not state any sale or transaction. It attributes reporting changes to an internal realignment; there is no explicit statement of sales, proceeds, or trading activity in the provided excerpt.
Geron Corp

NASDAQ:GERN

View GERN Stock Overview

GERN Rankings

GERN Latest News

GERN Latest SEC Filings

GERN Stock Data

1.01B
635.04M
Biotechnology
Pharmaceutical Preparations
Link
United States
FOSTER CITY